Download PDF
Z Gastroenterol 2004; 42(7): 623-628
DOI: 10.1055/s-2004-813165
Übersicht

© Karl Demeter Verlag im Georg Thieme Verlag KG Stuttgart · New York

Diagnosis and Therapy of Intrahepatic Cholestasis of Pregnancy

Diagnose und Therapie der intrahepatischen SchwangerschaftscholestaseT. C. Paus1 , G. Schneider1 , P. van de Vondel2 , T. Sauerbruch1 , C. Reichel1
  • 1Department of Internal Medicine I, University of Bonn, Germany
  • 2Department of Gynecology and Obstetrics, University of Bonn, Germany
We are indebted to Priv.-Doz. Dr. Natalija Novak from the Department of Dermatology, University of Bonn, Germany for kindly providing the pictures in Figs. 1 a, b.
Further Information

Publication History

manuscript received: 5.1.2004

manuscript accepted: 29.3.2004

Publication Date:
12 July 2004 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die intrahepatische Schwangerschaftscholestase (ISC) bezeichnet ein Syndrom, das durch Pruritus in der Spätschwangerschaft gekennzeichnet ist. Die Diagnose der ISC erfolgt durch Ausschluss pruritogener Hauterkrankungen und den Nachweis von erhöhten Gesamtgallensäuren-Serumkonzentrationen. Es gibt Hinweise auf eine genetische Prädisposition. Zahlreiche Studien haben den Stellenwert von Mutationen in bekannten Cholestase-Genen wie ABCB4 (auch MDR3 genannt), ABCB11 (BSEP) und ATP8B1 (FIC1) für die Entwicklung einer ISC untersucht. Die bisher vorliegenden Daten weisen auf eine heterogene Ätiologie des Syndroms hin. Die ISC scheint mit einem erhöhten Risiko von Früh- und Totgeburten des Kindes vergesellschaftet zu sein. Weiterhin kann die Symptomatik in Einzelfällen sehr stark sein und eine frühzeitige Entbindung mit den dazugehörigen Risiken für Mutter und Kind erzwingen. Schwangerschaften von Patientinnen mit ISC sind daher als Risikoschwangerschaften einzuschätzen. Therapien zur Verminderung des Pruritus oder der Cholestase durch Antihistaminika, Phenobarbital, Anionenaustauscher, Dexamethason und S-Adenosylmethionin sind nur begrenzt wirksam oder werden wegen ihrer Nebenwirkungen nur selten eingesetzt. Neuere kontrollierte Studien zeigen, dass Ursodeoxycholsäure (UDCA) einen positiven Effekt auf Juckreiz und laborchemische Veränderungen bei ISC hat. Die weitere Aufklärung der molekularen Ursachen der ISC wird in Zukunft eventuell zur gezielteren und wirkungsvolleren Therapie des Krankheitsbildes beitragen.

Abstract

Intrahepatic cholestasis of pregnancy (ICP) is characterized by the occurrence of pruritus mostly in the third trimenon. Diagnosis is based on the presence of pruritus and elevated levels of serum bile acids in the absence of pruritic skin diseases. There is strong evidence of a genetic predisposition for ICP. Numerous studies have investigated the association of known cholestasis genes such as ABCB4 (also designated MDR3), ABCB11 (BSEP) and ATP8B1 (FIC1) with ICP. The results of these studies implicate a heterogeneous etiology of this syndrome. ICP increases the risk of preterm delivery and fetal loss. Furthermore, intense pruritus may necessitate premature induction of labor with its known higher frequency of complications for mother and child. Therefore, ICP pregnancies should be managed as high-risk pregnancies. Pharmaceuticals to alleviate pruritus or improve cholestasis like antihistamines, phenobarbital, anion exchange resins, dexamethasone or S-adenosylmethionine are not widely accepted because of questionable efficacy or side effects. Recent randomized studies have shown beneficial effects of ursodeoxycholic acid (UDCA) on laboratory data and pruritus in patients with ICP. Improved knowledge about the diagnostic classification of different types and pathophysiological mechanisms of ICP may allow for a more targeted treatment of this disease in future.

Schlüsselwörter

Intrahepatische Schwangerschaftscholestase - pruritogene Hauterkrankungen - Gallensäuren-Serumkonzentration - progressive familial intrahepatishe Cholestase - low-phospholipid-assoziierte Cholelithiasis - ABCB4 Gen - ABCB11 Gen - ATP8B1 Gen

Key words

Intrahepatic cholestasis of pregnancy - pruritus - serum bile acids - progressive familial intrahepatic cholestasis - low phospholipid-associated cholelithiasis - ABCB4 gene - ABCB11 gene - ATP8B1 gene

References

  • 1 Ahlfeld F. Berichte und Arbeiten aus der Geburtshilflich-Gynäkologischen Klinik zu Gießen 1881 - 1882. Leipzig; Grunow 1883
    Google Scholar
  • 2 Bacq Y. Intrahepatic cholestasis of pregnancy.  Clinics Liver Dis. 1999;  3 1-13
    PubMedGoogle Scholar
  • 3 Savander M, Ropponen A, Avela K. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy.  Gut. 2003;  52 1025-1029
    CrossrefPubMedGoogle Scholar
  • 4 Bacq Y, Sapey T, Brechot M C. et al . Intrahepatic cholestasis of pregnancy: a French prospective study.  Hepatology. 1997;  26 358-364
    CrossrefPubMedGoogle Scholar
  • 5 Rioseco A J, Ivankovic M B, Manzur A. et al . Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome.  Am J Obstet Gynecol. 1994;  170 890-895
    CrossrefPubMedGoogle Scholar
  • 6 Shaw D, Frohlich J, Wittmann B A. et al . A prospective study of 18 patients with cholestasis of pregnancy.  Am J Obstet Gynecol. 1982;  142 (6 Pt 1) 621-625
    PubMedGoogle Scholar
  • 7 Alsulyman O M, Ouzounian J G, Ames-Castro M. et al . Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management.  Am J Obstet Gynecol. 1996;  175 (4 Pt 1) 957-960
    CrossrefPubMedGoogle Scholar
  • 8 Berg B, Helm G, Petersohn L. et al . Cholestasis of pregnancy. Clinical and laboratory studies.  Acta Obstet Gynecol Scand. 1986;  65 107-113
    CrossrefPubMedGoogle Scholar
  • 9 Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy.  Int J Gynaecol Obstet. 1984;  22 91-94
    CrossrefPubMedGoogle Scholar
  • 10 Jacquemin E, Cresteil D, Manouvrier S. et al . Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy.  Lancet. 1999;  353 (9148) 210-211
    CrossrefPubMedGoogle Scholar
  • 11 Dixon P H, Weerasekera N, Linton K J. et al . Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.  Hum Mol Genet. 2000;  9 1209-1217
    CrossrefPubMedGoogle Scholar
  • 12 Lucena J F, Herrero J I, Quiroga J. et al . A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis.  Gastroenterology. 2003;  124 1037-1042
    CrossrefPubMedGoogle Scholar
  • 13 De Vree J M, Jacquemin E, Sturm E. et al . Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.  Proc Natl Acad Sci USA. 1998;  95 282-287
    CrossrefPubMedGoogle Scholar
  • 14 Jacquemin E, De Vree J M, Cresteil D. et al . The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood.  Gastroenterology. 2001;  120 1448-1458
    CrossrefPubMedGoogle Scholar
  • 15 Simon E, Marschall H U, Glantz A. et al . Mutations of hepatocanalicular ABC transporters in intrahepatic cholestasis of pregnancy (ICP).  Hepatology. 2002;  36 (4 Pt. 2) 687
    CrossrefPubMedGoogle Scholar
  • 16 Glantz A, Marschall H U, Lammert F. et al . Intrahepatic cholestasis of pregnancy: A placebo-controlled randomised trial of ursodeoxycholic acid vs dexamethasone on maternal and fetal outcome and metabolism. Abstract from: Bile acids: From genomics to disease and therapy. XVII International Bile Acid Meeting 2002, Falk Symposium No. 129. 
    PubMedGoogle Scholar
  • 17 Huchzermeyer H. Leber und Schwangerschaft. Bern; Huber 1978
    Google Scholar
  • 18 Olsson R, Tysk C, Aldenborg F. et al . Prolonged postpartum course of intrahepatic cholestasis of pregnancy.  Gastroenterology. 1993;  105 267-271
    PubMedGoogle Scholar
  • 19 Brites D, Rodrigues C M, Oliveira N. et al . Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.  J Hepatol. 1998;  28 91-98
    PubMedGoogle Scholar
  • 20 Carter J. Serum bile acids in normal pregnancy.  Br J Obstet Gynaecol. 1991;  98 540-543
    CrossrefPubMedGoogle Scholar
  • 21 Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy.  Obstet Gynecol. 1983;  61 581-587
    PubMedGoogle Scholar
  • 22 Lunzer M, Barnes P, Byth K. et al . Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis.  Gastroenterology. 1986;  91 825-829
    CrossrefPubMedGoogle Scholar
  • 23 Van Dyke R W. The liver in pregnancy. In: Zakim D, Boyer TD (eds). Hepatology. A Textbook of Liver Disease. Philadelphia; WB Saunders 1996: 1734-1759
    Google Scholar
  • 24 Roger D, Vaillant L, Fignon A. et al . Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women.  Arch Dermatol. 1994;  130 734-739
    CrossrefPubMedGoogle Scholar
  • 25 Braun-Falco O, Plewig G, Wolff H H. Dermatologie und Venerologie. Berlin, Heidelberg, New York; Springer 1997
    Google Scholar
  • 26 Kreek M J. Female sex steroids and cholestasis.  Semin Liver Dis. 1987;  7 8-23
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Samsioe G, Svendsen P, Johnson P. et al . Studies in cholestasis of pregnancy. V. Gallbladder disease, liver function tests, serum lipids and fatty acid composition of serum lecithin in the non-pregnant state.  Acta Obstet Gynecol Scand. 1975;  54 417-423
    PubMedGoogle Scholar
  • 28 Glasinovic J C. et al .Pregnancy and gallstones. In: Reyes HB, Leuschner U, Arias I (eds). Pregnancy, Sex Hormones and the Liver. Dordrecht; Kluwer 1996: 267-281
    Google Scholar
  • 29 Stieger B, Fattinger K, Madon J. et al . Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.  Gastroenterology. 2000;  118 422-430
    CrossrefPubMedGoogle Scholar
  • 30 Bossard R, Stieger B, O‘Neill B. et al . Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver.  J Clin Invest. 1993;  91 2714-2720
    CrossrefPubMedGoogle Scholar
  • 31 Kullak-Ublick G A, Stieger B, Hagenbuch B. et al . Hepatic transport of bile salts.  Semin Liver Dis. 2000;  20 273-292
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Trauner M, Meier P J, Boyer J L. Molecular pathogenesis of cholestasis.  N Engl J Med. 1998;  339 1217-1227
    CrossrefPubMedGoogle Scholar
  • 33 Sjovall J, Sjovall K. Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels.  Ann Clin Res. 1970;  2 321-337
    PubMedGoogle Scholar
  • 34 Meng L J, Reyes H, Axelson M. et al . Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.  Hepatology. 1997;  26 1573-1579
    CrossrefPubMedGoogle Scholar
  • 35 Holzbach R T, Sivak D A, Braun W E. Familial recurrent intrahepatic cholestasis of pregnancy: a genetic study providing evidence for transmission of a sex-limited, dominant trait.  Gastroenterology. 1983;  85 175-179
    PubMedGoogle Scholar
  • 36 Dalen E, Westerholm B. Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters.  Acta Med Scand. 1974;  195 459-463
    PubMedGoogle Scholar
  • 37 Hirvioja M L, Kivinen S. Inheritance of intrahepatic cholestasis of pregnancy in one kindred.  Clin Genet. 1993;  43 315-317
    PubMedGoogle Scholar
  • 38 Mella J G, Roschmann E, Glasinovic J C. et al . Exploring the genetic role of the HLA-DPB1 locus in Chileans with intrahepatic cholestasis of pregnancy.  J Hepatol. 1996;  24 320-333
    CrossrefPubMedGoogle Scholar
  • 39 Deleuze J F, Jacquemin E, Dubuisson C. et al . Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.  Hepatology. 1996;  23 904-908
    CrossrefPubMedGoogle Scholar
  • 40 Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis.  Gastroenterology. 2001;  120 1459-1467
    CrossrefPubMedGoogle Scholar
  • 41 Rosmorduc O, Hermelin B, Boelle P Y. et al . ABCB4 gene mutation-associated cholelithiasis in adults.  Gastroenterology. 2003;  125 452-459
    CrossrefPubMedGoogle Scholar
  • 42 Lammert F, Carey M C, Paigen B. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map.  Gastroenterology. 2001;  120 221-238
    CrossrefPubMedGoogle Scholar
  • 43 De Pagter A G, van Berge Henegouwen GP. et al .
    PubMed
  • 44 Whitington P F, Freese D K, Alonso E M. et al . Clinical and biochemical findings in progressive familial intrahepatic cholestasis.  J Pediatr Gastroenterol Nutr. 1994;  18 134-341
    PubMedGoogle Scholar
  • 45 Stieger B. FIC1: another bile salt carrier within the enterohepatic circulation?.  J Hepatol. 2001;  35 522-524
    CrossrefPubMedGoogle Scholar
  • 46 Jansen P L, Strautnieks S S, Jacquemin E. et al . Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.  Gastroenterology. 1999;  117 1370-1379
    CrossrefPubMedGoogle Scholar
  • 47 Nishida T, Gatmaitan Z, Che M. et al . Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system.  Proc Natl Acad Sci USA. 1991;  88 6590-6594
    CrossrefPubMedGoogle Scholar
  • 48 Eloranta M L, Hakli T, Hiltunen M. et al . Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy.  Scand J Gastroenetrol. 2003;  38 648-652
    PubMedGoogle Scholar
  • 49 Sadler L C, Lane M, North R. Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy.  Br J Obstet Gynaecol. 1995;  102 169-170
    PubMedGoogle Scholar
  • 50 Heikkinen J, Maentausta O, Ylostalo P. et al . Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine.  Eur J Obstet Gynecol Reprod Biol. 1982;  14 153-162
    CrossrefPubMedGoogle Scholar
  • 51 Frezza M, Surrenti C, Manzillo G. et al . Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study.  Gastroenterology. 1990;  99 211-215
    PubMedGoogle Scholar
  • 52 Ribalta J, Reyes H, Gonzales M C. et al . S-Adenosyl-l-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results.  Hepatology. 1991;  13 1084-1089
    CrossrefPubMedGoogle Scholar
  • 53 Hirvioja M L, Tuimala R, Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone.  Br J Obstet Gynaecol. 1992;  99 109-111
    PubMedGoogle Scholar
  • 54 Floreani A, Paternoster D, Melis A. et al . S-Adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial.  Eur J Obstet Gynecol Reprod Biol. 1996;  67 109-113
    CrossrefPubMedGoogle Scholar
  • 55 Palma J, Reyes H, Axelson M. et al . Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo.  J Hepatol. 1997;  27 1022-1028
    CrossrefPubMedGoogle Scholar
  • 56 Schmid R, Haemmerli U P. Der Schwangerschaftsikterus. In: Beck K (ed). Ikterus. Stuttgart; Schattauer 1968: 227-231
    Google Scholar

Priv.-Doz. Dr. med. Christoph Reichel

Hartwald-Rehabilitationsklinik der BfA

Schlüchtener Straße 4

97769 Bad Brückenau, Germany

Email: drmed.christoph.reichel@bfa.de

      >